Last reviewed 2026-04-22 · How we verify

Adjuvanted Hepatitis B vaccine Lot 1

Henogen · Phase 3 active Biologic

Adjuvanted Hepatitis B vaccine Lot 1 is a Vaccine Biologic drug developed by Henogen. It is currently in Phase 3 development for Prevention of hepatitis B infection.

This adjuvanted hepatitis B vaccine stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus surface antigen.

This adjuvanted hepatitis B vaccine stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus surface antigen. Used for Prevention of hepatitis B infection.

At a glance

Generic name	Adjuvanted Hepatitis B vaccine Lot 1
Sponsor	Henogen
Drug class	Vaccine
Target	Hepatitis B surface antigen (HBsAg)
Modality	Biologic
Therapeutic area	Immunology
Phase	Phase 3

Mechanism of action

The vaccine contains hepatitis B surface antigen (HBsAg) combined with an adjuvant that enhances the immunogenicity of the antigen. The adjuvant amplifies the body's innate immune response, leading to stronger and more durable antibody production and T-cell activation against hepatitis B virus. This provides protective immunity against hepatitis B infection.

Approved indications

Prevention of hepatitis B infection

Common side effects

Injection site pain or erythema
Fatigue
Myalgia
Headache
Fever

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Adjuvanted Hepatitis B vaccine Lot 1 CI brief — competitive landscape report
Adjuvanted Hepatitis B vaccine Lot 1 updates RSS · CI watch RSS
Henogen portfolio CI

Frequently asked questions about Adjuvanted Hepatitis B vaccine Lot 1

What is Adjuvanted Hepatitis B vaccine Lot 1?

Adjuvanted Hepatitis B vaccine Lot 1 is a Vaccine drug developed by Henogen, indicated for Prevention of hepatitis B infection.

How does Adjuvanted Hepatitis B vaccine Lot 1 work?

This adjuvanted hepatitis B vaccine stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus surface antigen.

What is Adjuvanted Hepatitis B vaccine Lot 1 used for?

Adjuvanted Hepatitis B vaccine Lot 1 is indicated for Prevention of hepatitis B infection.

Who makes Adjuvanted Hepatitis B vaccine Lot 1?

Adjuvanted Hepatitis B vaccine Lot 1 is developed by Henogen (see full Henogen pipeline at /company/henogen).

What drug class is Adjuvanted Hepatitis B vaccine Lot 1 in?

Adjuvanted Hepatitis B vaccine Lot 1 belongs to the Vaccine class. See all Vaccine drugs at /class/vaccine.

What development phase is Adjuvanted Hepatitis B vaccine Lot 1 in?

Adjuvanted Hepatitis B vaccine Lot 1 is in Phase 3.

What are the side effects of Adjuvanted Hepatitis B vaccine Lot 1?

Common side effects of Adjuvanted Hepatitis B vaccine Lot 1 include Injection site pain or erythema, Fatigue, Myalgia, Headache, Fever.

What does Adjuvanted Hepatitis B vaccine Lot 1 target?

Adjuvanted Hepatitis B vaccine Lot 1 targets Hepatitis B surface antigen (HBsAg) and is a Vaccine.

Drug class: All Vaccine drugs
Target: All drugs targeting Hepatitis B surface antigen (HBsAg)
Manufacturer: Henogen — full pipeline
Therapeutic area: All drugs in Immunology
Indication: Drugs for Prevention of hepatitis B infection
Compare: Adjuvanted Hepatitis B vaccine Lot 1 vs similar drugs
Pricing: Adjuvanted Hepatitis B vaccine Lot 1 cost, discount & access